LncRNA H19/miRNA-21a-5p信号通路在BMP2调控发育性髋关节发育不良的髋臼软骨内骨化中的作用及分子机制
批准号:
82102519
项目类别:
青年科学基金项目(C类)
资助金额:
30.0 万元
负责人:
代光明
依托单位:
学科分类:
运动系统结构、功能和发育异常
结题年份:
2024
批准年份:
2021
项目状态:
已结题
项目参与者:
代光明
中文摘要
发育性髋关节发育不良(DDH)的髋臼软骨内骨化明显延迟,因此调控软骨内骨化对治疗DDH具有重要价值。BMP2具有诱导软骨内骨化的重要作用。申请人前期研究发现H19具有调控BMP2诱导的软骨内骨化作用,当前实验证实这与miRNA-21a-5p相关。提出基于H19/miRNA-21a-5p调控BMP2诱导软骨内成骨用于治疗DDH髋臼软骨内骨化延迟的科学假设。本课题旨在前期研究的基础上,通过构建表达BMP2和沉默H19的软骨细胞及制备肥大软骨细胞内敲出H19的小鼠DDH模型,采用原位杂交、免疫组化、基因芯片等技术检测H19/miRNA-21a-5p对BMP2诱导的软骨内骨化是否具有调控作用及对DDH髋臼软骨内骨化的作用,从而阐明H19/miRNA-21a-5p调控BMP2诱导的软骨内骨化对DDH的修复作用。这不仅为DDH髋臼发育机制研究提供了新的视点,同时为针对DDH早期治疗的药物研制奠定基础。
英文摘要
Acetabular endochondral ossification in developmental dysplasia of hip (DDH) is significantly delayed, so the regulation of endochondral ossification is of great value in the treatment of DDH. Current studies have confirmed that BMP2 plays an important role in inducing chondrocyte hypertrophy and endochondral ossification. The applicant found that H19 can regulate the hypertrophic differentiation of chondrocyte and endochondral ossification induced by BMP2, which reported in our previous study, and the current experiment preliminarily confirmed that this is related to miRNA-21a-5p. Therefore, we propose a scientific hypothesis that endochondral ossification induced by BMP2 is regulated by H19/miRNA-21a-5p, to which treat delayed acetabular ossification in DDH. On the basis of previous studies, the purpose of this study was to establish a mouse DDH model of H19 conditional knockout in hypertrophic chondrocytes and to construct chondrocytes stably expressing BMP2 and silencing H19 expression. In situ hybridization, immunohistochemistry and gene chip were used to detect the regulation of H19/miRNA-21a-5p signal pathway on BMP2-induced endochondral ossification and acetabular endochondral ossification of DDH. This will elucidate the role of H19/miRNA-21a-5p signaling pathway in regulating the repair of BMP2-induced endochondral ossification on acetabular dysplasia in DDH. This not only provides a new perspective for the study of the mechanism of acetabular development in DDH, but also lays a solid foundation for the research and development of drugs for early treatment of DDH.
儿童发育性髋关节发育不良(DDH)的主要临床表现为髋臼对股骨头的包容覆盖不足,前期国内外研究认为髋臼发育不良是其主要病因,其分子病理机制是软骨内骨化明显延迟,因此调控软骨内骨化对治疗DDH可能具有重要应用价值。既往研究发现BMP2具有诱导软骨内骨化的重要作用,而且申请人的前期研究结果发现H19具有调控BMP2诱导的软骨内骨化作用,另外我们通过进一步探索实验发现这与miRNA-21a-5p可能相关。因此,本项目我们提出基于H19/miRNA-21a-5p调控BMP2诱导软骨内成骨用于治疗DDH髋臼软骨内骨化延迟的科学假设。本项目旨在前期研究的基础上,通过构建表达BMP2和沉默H19的软骨细胞及制备肥大软骨细胞内敲出H19的小鼠DDH模型,采用原位杂交、免疫组化、基因芯片等技术检测H19/miRNA-21a-5p对BMP2诱导的软骨内骨化是否具有调控作用及对DDH髋臼软骨内骨化的作用。本项目研究结果中,我们首先成功构建了小鼠DDH模型,并发现DDH髋臼软骨内骨化过程受到明显抑制,而注射BMP2可以部分缓解该抑制效应。另外,我们检测发现LncRNA H19在小鼠肢体发育过程中于软骨内骨化区域高表达,提示其与调节软骨内骨化过程有明显相关性。接着,我们在体外实验证实了LncRNA H19能够调控BMP2诱导的软骨内骨化过程。其分子机制是LncRNA H19可以直接靶向调节miRNA-21a-5p而促进于Smad7发挥作用。而且我们通过FISH实验检测LncRNA H19在肢体发育中的表达,结果中发现LncRNA H19除了高表达在成骨区域外,其在肥大软骨区域也明显高表达,这说明LncRNA H19调节软骨内骨化过程与肥大软骨细胞有明显关系。接着我们通过DTA f/+;Col10α1-Cre+转基因小鼠的构建发现软骨内骨化中关键效应细胞可能就是肥大软骨细胞,而进一步发现肥大软骨细胞转分化调控对软骨内骨化具有关键调控作用。这些结果对肥大软骨细胞特异性调控LncRNA H19/miRNA-21a-5p介导的软骨内成骨对发育性髋关节发育不良的修复作用有明显的预示性。最后,我们通过肥大软骨细胞LncRNA H19特异性敲除发现其明显抑制髋关节发育,主要表现为髋臼软骨内骨化抑制。这研究发现和理论的提出不仅为DDH髋臼发育机制研究提供了新的视点,同时为针对DDH早期治疗的药物研制奠定基础。
肥大软骨细胞内质网应激(ERS)经转分化重编程调控软骨内骨化的新机制及在骨折修复中的作用研究
-
批准号:--
-
项目类别:省市级项目
-
资助金额:0.0万元
-
批准年份:2025
-
负责人:代光明
-
依托单位:
国内基金
海外基金